Showing 1 - 10 of 124
It is acknowledged that economic evaluation methods as they have been developed for Health Technology Assessment do not capture all the costs and benefits relevant to the assessment of public health interventions. This paper reviews methods that could be employed to measure and value the broader...
Persistent link: https://www.econbiz.de/10009753411
Persistent link: https://www.econbiz.de/10012510363
Persistent link: https://www.econbiz.de/10012512796
Persistent link: https://www.econbiz.de/10012664720
Persistent link: https://www.econbiz.de/10012666323
The Ghanaian National Health Insurance Scheme pays providers according to the fee for service payment scheme, a method of payment that is likely to encourage inducement of care. The goal of this paper is to test for the presence of supplier induced demand among patients who received care in...
Persistent link: https://www.econbiz.de/10009503928
Several experimental studies have observed substantial violations of transitivity for decisions between risky lotteries over monetary outcomes. The goal of our experiment is to test whether these violations also affect the evaluation of health states. A particular feature of our experimental...
Persistent link: https://www.econbiz.de/10009503929
Background: In the day surgery system are intertwined elements of state health policy, health care payers' interests, employers of health care system, as well as the interests and wishes of patients. A problem in the health policy is to find a way to regulate ambulatory and short-term surgical...
Persistent link: https://www.econbiz.de/10010526630
Background: The amount of out-of-pocket (OOP) payments within the German health care system has risen steadily within the last years. OOP payments aim to strengthen patients' cost awareness and try to restrict the demand on medical necessary treatments. However, besides the intended decline of...
Persistent link: https://www.econbiz.de/10010526631
The next generation of artificial vision devices (AVDs), which is currently developed in pre-clinical settings, has the potential to improve the vision of blind patients with retinitis pigmentosa (RP) in a manner that they will be categorized as visual impaired but no more as blind. This...
Persistent link: https://www.econbiz.de/10010526936